Neuren Pharmaceuticals | NEU - Capital Ordinário





Capital Ordinário Alterar Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Clinuvel Pharmaceuticals AUD 50.2M 77.11K 2025-12
Dianthus Therapeutics USD 54.58M 11.36M 2026-03
Genetic Signatures AUD 227.14M 0 2025-12
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organon & Co USD 262.61M 40K 2026-06
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
PYC Therapeutics AUD 597.24M 366.66M 2025-12
Starpharma Holdings AUD 419.92M 179.17M 2025-12
Tectonic Therapeutic USD 18.83M 92.19K 2026-03
Telix Pharmaceuticals AUD 339.78M 1.01M 2026-06
Viatris USD 1.16B 9.19M 2026-06
Xeris Pharmaceuticals USD 172.56M 6.34M 2026-03